Media Release: PATH Malaria Vaccine Initiative Names New Director of Research & Development
Excerpt
WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ — The PATH Malaria Vaccine Initiative (MVI) announced today that C. Richter (Rick) King, PhD, has been named Director of Research & Development (R&D). MVI drives the development of safe and effective vaccines to combat malaria. Malaria still kills more than 600,000 people worldwide, and half the world’s population remains at risk of contracting the disease.

Dr. King is an accomplished scientist with more than 25 years of experience in the public and private sectors, in both for-profit and nonprofit organizations. Most recently he served as Vice President of Vaccine Design for the International AIDS Vaccine Initiative (IAVI), within their Vaccine Design & Development Laboratory, a role he held for five years…

…Dr. King will lead work around transmission-blocking vaccines, a priority area of product development for MVI. He will also guide MVI’s portfolio of evaluation technology projects, which aim to refine or develop ways to assess vaccine efficacy prior to large-scale field trials…

…”Advancing new treatments and preventions have been a life-long passion,” said Dr. King, “and I am excited to be on the cutting edge of the malaria vaccine development field. I can’t wait to get started.”…